Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

STO/ACARIX stock hub

STO/ACARIX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

STO/ACARIXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

307.5M

Nasdaq Stockholm

Market data

Price

Recent price action with selectable time range.

STO/ACARIXSTO/ACARIX

—

Loading chart…

In the news

Latest news · STO/ACARIX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-84.5

P25 n/aP50 n/aP75 n/a

ROIC-52.7

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All STO/ACARIX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

170

Groups with data

Currency

SEK

Showing 170 of 170 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	SE
Employees	8
Employees Change	-6%
Employees Change Percent	-42.86
Enterprise value	SEK 289.1M
Exchange	Nasdaq Stockholm
Financial currency	SEK
First seen	2026-05-10
Industry	Medical Devices
Isin	SE0009268717
Last refreshed	2026-05-10
Market cap	SEK 307.5M
Price	SEK 0.26
Price currency	SEK
Rev Per Employee	920,125x
Sector	Healthcare
Sic	3845
Symbol	sto/ACARIX
Website	https://www.acarix.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-15.64%
EV Earnings	-6.01x
EV/FCF	-7.6x
EV/Sales	39.27x
FCF yield	-12.37%
P/B ratio	8.06x
P/S ratio	41.77x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	84.74%
Gross Profit	SEK 6.2M
Gross Profit Growth	11.49%
Gross Profit Growth Q	18.52%
Gross Profit Growth3 Y	10.52%
Gross Profit Growth5 Y	31.37%
Net Income	SEK -48.1M
Net Income Growth Quarters	5%
Net Income Growth Years	2%
Pretax Margin	-653.32%
Profit Per Employee	SEK -6M
ROA	-46.49
Roa5y	-51.86
ROCE	-125.8
ROE	-84.47
Roe5y	-99.2
ROIC	-52.71

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	34.86%
Cagr3y	-19.09%
Cagr5y	-30.11%
EPS Growth Quarters	12
EPS Growth Years	6
Revenue Growth	18.69x
Revenue Growth Q	26.02x
Revenue Growth Quarters	2x
Revenue Growth Years	1x
Revenue Growth3 Y	8.13x
Revenue Growth5 Y	27.67x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	SEK 0.11
Assets	SEK 48.3M
Cash	SEK 18.4M
Current Assets	SEK 41.5M
Current Liabilities	SEK 10.2M
Equity	SEK 38.2M
Liabilities	SEK 10.2M
Long Term Assets	SEK 6.8M
Long Term Liabilities	SEK 0
Net Cash	SEK 18.4M
Net Cash By Market Cap	SEK 5.99
Net Cash Growth	-68.65%
Net Debt Equity	SEK -0.48
Tangible Book Value	SEK 35.1M
Tangible Book Value Per Share	SEK 0.03
WACC	2.84

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.08
Inventory Turnover	0.17
Net Working Capital	SEK 12.9M
Quick ratio	3.36
Working Capital	SEK 31.3M
Working Capital Turnover	SEK 0.15

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-22.37%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	34.83%
200-day SMA	0.3
3Y total return	-47.04%
50-day SMA	0.28
50-day SMA vs 200-day SMA	50under200
5Y total return	-83.32%
All Time High	26.8
All Time High Change	-99.01%
All Time High Date	2016-12-27
All Time Low	0.17
All Time Low Change	56.4%
All Time Low Date	2024-12-02
ATR	0.02
Beta	-0.26
Beta1y	0.34
Beta2y	-0.31
Ch YTD	-1.49
High	0.27
High52	0.47
High52 Date	2025-07-16
High52ch	-43.95%
Low	0.26
Low52	0.19
Low52 Date	2025-05-13
Low52ch	37.93%
Ma50ch	-5.71%
Price vs 200-day SMA	-10.93%
RSI	40.48
RSI Monthly	44.09
RSI Weekly	44.72
Sharpe ratio	0.61x
Sortino ratio	1.16
Total Return	-22.37%
Tr YTD	-1.49
Tr1m	-4.35%
Tr1w	-0.38%
Tr3m	-5.71%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SEK -48M
Operating margin	-652.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,025,846,096%
Shares Insiders	10.16%
Shares Institutions	27.18%
Shares Out	1,164,697,336
Shares Qo Q	1.23%
Shares Yo Y	22.37%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	SEK -38M
Average Volume	1,292,296.65x
Bv Per Share	0.03
CAPEX	SEK -757,000
Ch1m	-4.35
Ch1w	-0.38
Ch1y	34.83
Ch3m	-5.71
Ch3y	-47.04
Ch5y	-84.58
Ch6m	-3.3
Change	-0.56%
Change From Open	1.15
Close	0.27
Days Gap	-1.69
Depreciation Amortization	1,050,000
Dollar Volume	149,090.8
Earnings Date	2026-04-15
EBIT	SEK -48M
EBITDA	SEK -47M
EPS	SEK -0.04
F Score	2
FCF	SEK -38M
FCF EV Yield	-13.16x
FCF Per Share	SEK -0.03
Fiscal Year End	December
Founded	2,009
Investing CF	-757,000
Is Primary Listing	1
Last Earnings Date	2026-04-15
Last Report Date	2025-12-31
Ma150	0.28
Ma150ch	-6.61%
Ma20	0.28
Ma20ch	-6.28%
Net CF	-40,341,000
Next Earnings Date	2026-05-18
Open	0.26
Position In Range	75
Ppne	372,000
Price Date	2026-05-08
Ptbv Ratio	8.77
Relative Volume	0.38x
Revenue	7,361,000x
Tr6m	-3.3%
Volume	564,738
Z Score	-3.09

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does STO/ACARIX pay a dividend?

Capital-return profile for this ticker.

Performance

STO/ACARIX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns STO/ACARIX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+27.2%

Share of float held by funds and institutions

Insider ownership

+10.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+22.4%

Negative means the company is buying back shares.

Technical

STO/ACARIX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.5

Neutral momentum band

Price vs 200-day MA

-10.9%

50/200-day relationship not available

Beta (5Y)

-0.26

Less volatile than the market

Sharpe ratio

0.61

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About STO/ACARIX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sto/ACARIX stock rating?

sto/ACARIX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sto/ACARIX analysis?

The full report lives at /stocks/sto/ACARIX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sto/ACARIX?

The latest report frames sto/ACARIX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sto/ACARIX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.